SEE SCHEDULE OOUR MISSION IS TO IMPROVE EQUITY IN HEALTH CARE ACCESS AND OUTCOMES ACROSS GEOGRAPHIES, SOCIOECONOMICS, AND DEMOGRAPHICS ON A NOT-FOR-PROFIT, CHARITABLE BASIS. WE USE INNOVATIONS IN SCIENCE AND TECHNOLOGY TO CHALLENGE AND ADVANCE THE NORMS OF BIOPHARMA AND HEALTH CARE DELIVERY. OUR WORK IS ACROSS TWO STRATEGIES: (I) INVESTMENTS AND INCUBATION LEADERSHIP TO EARLY-STAGE INNOVATIVE HEALTH ACCESS, MANUFACTURING, AND DRUG DEVELOPMENT ORGANIZATIONS WITH NO OR LOW-COST "PATIENT" CAPITAL AND RESOURCES; (II) CHARITABLE PARTNERSHIPS AND EDUCATIONAL INITIATIVES ACROSS INDUSTRY, PATIENT ADVOCACY, AND INVESTORS ACCELERATING DEVELOPMENT OF NEW MEDICINES.
Executive compensation
Form 990 · Schedule J · 5 reported individuals · Filing year 2023
| Base salary | Executive compensation | |
|---|---|---|
Director and Treasurer officer (unspecified) $2.3M | ||
Director and Secretary officer (unspecified) $33k | ||
Director and Chair board chair $22k | ||
Director board member $9k | ||
Browse compensation in Philanthropy, Voluntarism & Grantmaking →
Down 95%
from 2022
From $47.2M in 2022 to $2.3M in 2023.
Among peers
Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.
Compare any role, sector, or revenue band
Build your own benchmark from millions of reported positions.